5 PM TODAY: Golden Buying Window to Ride India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of HINDUSTAN BIOSCIE. For more details, see the HINDUSTAN BIOSCIE quarterly results and HINDUSTAN BIOSCIE share price. For a sector overview, read our cement sector report.
1 Day | % | 2.4 |
No. of shares | m | 10.25 |
1 Week | % | 7.4 |
1 Month | % | 15.4 |
1 Year | % | - |
52 week H/L | Rs | 15.2/5.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
HINDUSTAN BIOSCIE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1 | 3 | 5 | 6 | 6 | |
Low | Rs | 1 | 1 | 1 | 3 | 3 | |
Sales per share (Unadj.) | Rs | 3.5 | 1.9 | 1.0 | 0.4 | 0.9 | |
Earnings per share (Unadj.) | Rs | 0.1 | 0.1 | -0.9 | -0.5 | 0 | |
Diluted earnings per share | Rs | 0.1 | 0.1 | -0.9 | -0.5 | -0.0 | |
Cash flow per share (Unadj.) | Rs | 0.1 | 0.1 | -0.9 | -0.5 | 0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 2.1 | 2.2 | 1.3 | 0.8 | 0.7 | |
Adj. book value per share | Rs | 2.1 | 2.2 | 1.3 | 0.8 | 0.7 | |
Shares outstanding (eoy) | m | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | |
Price / Sales ratio | x | 0.2 | 1.1 | 3.0 | 10.2 | 4.9 | |
Avg P/E ratio | x | 7.9 | 25.4 | -3.3 | -8.5 | -111.7 | |
P/CF ratio (eoy) | x | 7.2 | 22.3 | -3.4 | -8.6 | -130.2 | |
Price / Book Value ratio | x | 0.4 | 0.9 | 2.4 | 5.6 | 6.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 9 | 21 | 31 | 44 | 45 | |
Total wages/salary | Rs m | 2 | 2 | 2 | 2 | 2 |
HINDUSTAN BIOSCIE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 36 | 19 | 10 | 4 | 9 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 36 | 19 | 10 | 4 | 9 | |
Gross profit | Rs m | 1 | 1 | -9 | -5 | 0 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit before tax | Rs m | 1 | 1 | -10 | -5 | 0 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 1 | 1 | -9 | -5 | 0 | |
Gross profit margin | % | 3.7 | 7.0 | -91.1 | -117.4 | -3.1 | |
Effective tax rate | % | 2.1 | 30.7 | 1.6 | -0.6 | -6.6 | |
Net profit margin | % | 3.1 | 4.2 | -91.1 | -120.1 | -4.4 |
HINDUSTAN BIOSCIE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 20 | 23 | 10 | 5 | 9 | |
Current liabilities | Rs m | 10 | 16 | 14 | 11 | 14 | |
Net working cap to sales | % | 28.4 | 34.0 | -38.8 | -133.7 | -60.6 | |
Current ratio | x | 2.0 | 1.4 | 0.7 | 0.5 | 0.6 | |
Inventory Days | Days | 363 | 600 | 845 | 2,024 | 946 | |
Debtors Days | Days | 171,534,675 | 256,089,091 | 218,339,463 | 114,340,188 | 179,564,165 | |
Net fixed assets | Rs m | 36 | 32 | 24 | 24 | 24 | |
Share capital | Rs m | 103 | 103 | 103 | 103 | 21 | |
"Free" reserves | Rs m | -81 | -80 | -89 | -95 | -13 | |
Net worth | Rs m | 22 | 22 | 13 | 8 | 7 | |
Long term debt | Rs m | 25 | 17 | 7 | 11 | 11 | |
Total assets | Rs m | 56 | 55 | 35 | 30 | 33 | |
Interest coverage | x | 12.3 | 15.6 | -135.4 | -102.0 | -8.5 | |
Debt to equity ratio | x | 1.1 | 0.7 | 0.6 | 1.4 | 1.5 | |
Sales to assets ratio | x | 0.6 | 0.4 | 0.3 | 0.1 | 0.3 | |
Return on assets | % | 2.1 | 1.6 | -26.8 | -17.3 | -1.1 | |
Return on equity | % | 5.1 | 3.6 | -72.0 | -65.8 | -5.4 | |
Return on capital | % | 2.6 | 3.2 | -46.5 | -27.4 | -1.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 6 | 5 | 5 | 4 | 6 | |
Fx outflow | Rs m | 3 | 10 | 0 | 2 | 0 | |
Net fx | Rs m | 3 | -5 | 5 | 2 | 6 |
HINDUSTAN BIOSCIE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -13 | 8 | 8 | -3 | -1 | |
From Investments | Rs m | -0 | 0 | 0 | -0 | 0 | |
From Financial Activity | Rs m | 15 | -8 | -9 | 3 | 1 | |
Net Cashflow | Rs m | 2 | 0 | -2 | -0 | 0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: J V R Mohan Raju | COMP SEC: Kamala Kumar Tamada | YEAR OF INC: 1991 | BSE CODE: 532041 | FV (Rs): 2 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: ULTRATECH CEMENT AMBUJA CEMENT SHREE CEMENT RAIN INDUSTRIES SRI DIGVIJAY CEMENT
Compare HINDUSTAN BIOSCIE With: ULTRATECH CEMENT AMBUJA CEMENT SHREE CEMENT RAIN INDUSTRIES SRI DIGVIJAY CEMENT
Indian share markets continued the momentum as the session progressed and ended on firm footing.